Nitrate-Rich Beetroot Juice Reduces Blood Pressure in Tanzanian Adults with Elevated Blood Pressure: A Double-Blind Randomized Controlled Feasibility Trial.
Tanzania
blood pressure
dietary nitrate
folate supplementation
hypertension
Journal
The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
received:
29
01
2020
revised:
11
03
2020
accepted:
21
05
2020
pubmed:
31
7
2020
medline:
17
12
2020
entrez:
31
7
2020
Statut:
ppublish
Résumé
In Sub-Saharan Africa, current strategies are struggling to control the burgeoning hypertension epidemic. Dietary interventions such as inorganic nitrate or folic acid supplementation could represent promising strategies for reducing blood pressure (BP) in this setting. This feasibility study explores the effects of dietary inorganic nitrate supplementation, alone or in combination with folic acid, on BP in Tanzanian adults with elevated BP in Tanzania. A placebo-controlled, double-blind, randomized controlled feasibility trial was conducted. Forty-seven middle-aged and older participants (age: 50-70 y, BMI: 26.3-29.1 kg/m2) were randomly assigned to 3 conditions for a period of 60 d: 1) high-nitrate beetroot juice (∼400 mg nitrate) and folic acid (∼5 mg folic acid) (N + F), 2) high-nitrate beetroot juice and placebo (N + P), or 3) nitrate-depleted beetroot juice and placebo (P + P). Clinic and 24-h ambulatory BP and measurements of compliance in plasma (nitrate and folate concentrations) and saliva (nitrate and nitrite) were obtained at baseline, 30 d, and 60 d. Baseline resting systolic and diastolic BP (mean ± SD) was 151.0 ± 19.4 mm Hg and 91.8 ± 11.7 mm Hg, respectively. Compliance to the interventions was high (>90%) in all groups which was confirmed by the significant increase in nitrate and folic acid concentrations in plasma and saliva samples in the treatment arms. After 60 d, 24-h systolic BP dropped by -10.8 ± 9.8 mm Hg (P < 0.001), -6.1 ± 13.2 mm Hg (P = 0.03), and -0.3 ± 9.7 mm Hg (P = 0.83) in the N + P, N + F, and P + P groups, respectively. There was a significant decrease in 24-h diastolic BP in the N + P group (-5.4 ± 5.0 mm Hg, P = 0.004), whereas changes were not significant in the N + F (-1.8 ± 8.1 mm Hg, P = 0.32) and P + P (1.6 ± 8.3 mm Hg, P = 0.43) groups. Dietary inorganic nitrate represents a potential nutritional strategy to lessen the hypertension epidemic in Sub-Saharan Africa. These findings support the rationale for future long-term investigations exploring the efficacy of dietary nitrate for lowering BP and attenuating cardiovascular disease risk in this setting.This trial was registered at isrctn.com as ISRCTN67978523.
Sections du résumé
BACKGROUND
In Sub-Saharan Africa, current strategies are struggling to control the burgeoning hypertension epidemic. Dietary interventions such as inorganic nitrate or folic acid supplementation could represent promising strategies for reducing blood pressure (BP) in this setting.
OBJECTIVES
This feasibility study explores the effects of dietary inorganic nitrate supplementation, alone or in combination with folic acid, on BP in Tanzanian adults with elevated BP in Tanzania.
METHODS
A placebo-controlled, double-blind, randomized controlled feasibility trial was conducted. Forty-seven middle-aged and older participants (age: 50-70 y, BMI: 26.3-29.1 kg/m2) were randomly assigned to 3 conditions for a period of 60 d: 1) high-nitrate beetroot juice (∼400 mg nitrate) and folic acid (∼5 mg folic acid) (N + F), 2) high-nitrate beetroot juice and placebo (N + P), or 3) nitrate-depleted beetroot juice and placebo (P + P). Clinic and 24-h ambulatory BP and measurements of compliance in plasma (nitrate and folate concentrations) and saliva (nitrate and nitrite) were obtained at baseline, 30 d, and 60 d.
RESULTS
Baseline resting systolic and diastolic BP (mean ± SD) was 151.0 ± 19.4 mm Hg and 91.8 ± 11.7 mm Hg, respectively. Compliance to the interventions was high (>90%) in all groups which was confirmed by the significant increase in nitrate and folic acid concentrations in plasma and saliva samples in the treatment arms. After 60 d, 24-h systolic BP dropped by -10.8 ± 9.8 mm Hg (P < 0.001), -6.1 ± 13.2 mm Hg (P = 0.03), and -0.3 ± 9.7 mm Hg (P = 0.83) in the N + P, N + F, and P + P groups, respectively. There was a significant decrease in 24-h diastolic BP in the N + P group (-5.4 ± 5.0 mm Hg, P = 0.004), whereas changes were not significant in the N + F (-1.8 ± 8.1 mm Hg, P = 0.32) and P + P (1.6 ± 8.3 mm Hg, P = 0.43) groups.
CONCLUSIONS
Dietary inorganic nitrate represents a potential nutritional strategy to lessen the hypertension epidemic in Sub-Saharan Africa. These findings support the rationale for future long-term investigations exploring the efficacy of dietary nitrate for lowering BP and attenuating cardiovascular disease risk in this setting.This trial was registered at isrctn.com as ISRCTN67978523.
Identifiants
pubmed: 32729923
pii: S0022-3166(22)02299-4
doi: 10.1093/jn/nxaa170
pmc: PMC7467850
doi:
Substances chimiques
Antihypertensive Agents
0
Banques de données
ISRCTN
['ISRCTN67978523']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2460-2468Subventions
Organisme : Medical Research Council
ID : MC_PC_16054
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N007921/1
Pays : United Kingdom
Informations de copyright
Copyright © The Author(s) on behalf of the American Society for Nutrition 2020.
Références
Lancet. 2016 Mar 5;387(10022):957-967
pubmed: 26724178
Hypertension. 2008 Mar;51(3):784-90
pubmed: 18250365
Am J Clin Nutr. 2009 Jul;90(1):1-10
pubmed: 19439460
Nutr Rev. 2017 Jan;75(1):61-70
pubmed: 27974600
Am J Clin Nutr. 2018 Dec 1;108(6):1352-1353
pubmed: 30379993
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
N Engl J Med. 2006 Dec 28;355(26):2792-3
pubmed: 17192551
Lancet. 2002 Nov 2;360(9343):1347-60
pubmed: 12423980
J Clin Hypertens (Greenwich). 2014 Aug;16(8):551-3
pubmed: 25040331
J Chiropr Med. 2009 Mar;8(1):15-24
pubmed: 19646382
J Nutr. 2013 Jun;143(6):818-26
pubmed: 23596162
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
Hypertension. 2015 Feb;65(2):320-7
pubmed: 25421976
J Inherit Metab Dis. 2011 Feb;34(1):75-81
pubmed: 20814827
Contemp Clin Trials Commun. 2019 Oct 15;16:100472
pubmed: 31872153
Cardiovasc J Afr. 2015 Jul-Aug;26(4):193-5
pubmed: 26407222
Free Radic Biol Med. 2013 Feb;55:93-100
pubmed: 23183324
Pharmacol Res. 2017 Aug;122:127-129
pubmed: 28610958
Nitric Oxide. 2018 Jan 30;72:66-74
pubmed: 29223585
Nitric Oxide. 2018 Apr 1;74:39-46
pubmed: 29360600
Afr J Phys Health Educ Recreat Dance. 2013 Nov;2013(Suppl 1):47-57
pubmed: 26594665
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
Nutr Rev. 2018 May 1;76(5):348-371
pubmed: 29506204
J Hum Hypertens. 2013 Jun;27(6):374-80
pubmed: 23235367
Front Pharmacol. 2017 Aug 31;8:585
pubmed: 28912716
Clin Nutr. 2020 Mar;39(3):708-717
pubmed: 30930132
Am J Clin Nutr. 2018 Jun 1;107(6):894-908
pubmed: 29868911
ISRN Physiol. 2014 Feb 23;2014:
pubmed: 25401100
Stat Methods Med Res. 2016 Jun;25(3):1057-73
pubmed: 26092476